The global bioanalytical testing services market size is expected to reach USD 6.34 billion by 2028 according to a new study by Polaris Market Research. The report “Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report, By Molecule Type (Small Molecule, Large Molecule); By Test Type; By Workflow; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth
Bioanalytical testing is the most crucial process involved in the process of drug discovery and development. Bioanalytical methods are employed in pharmacokinetics, bioequivalence, toxicology, pharmacology, and bioavailability studies in humans or animals for the quantitative analysis of drugs in biological samples such as plasma, serum, urine, or other biological systems.
Request A Sample Report At: https://www.polarismarketresearch.com/industry-analysis/bioanalytical-testing-services-market/request-for-sample
Now, pharmacokinetic characterization of a novel chemical drug candidate is conducted from the initial process of drug discovery to the advanced stages of drug development. ADME/PK screening is used to study metabolism and absorption, and the testing is initially carried out in in-vitro systems. Still, however, in-vivo studies are carried out in later stages of pre-clinical development for definitive assessment of overall drug disposition.
In previous decades ADME/PK studies were carried out at later stages of clinical development. Hence, many new chemical entities failed at later development stages due to shortcomings in metabolism and PK. In-vitro approaches in ADME/PK at an earlier stage in the drug development process will minimize the failure of a drug candidate at later stages.
The development of innovative drugs in the market, the emergence of biosimilars, and increasing numbers of CROs across the globe are the primary driving force behind the growth of the global testing services market. Companies are also raising funds and going for acquisition and collaboration to develop and commercialize new bioanalytical platforms.
In January 2021, Adeptrix Corp raised Series A investment to accelerate its proprietary BAMS platform technology commercialization. The company has recently entered into many research partnerships to develop rapid and accurate COVID-19 diagnostics based on its Bead Assisted Mass Spectrometry.
Request for Discount Pricing With Your Specific Research Needs At: https://www.polarismarketresearch.com/industry-analysis/bioanalytical-testing-services-market/request-for-discount-pricing
During the same time, Nexelis acquired a GCLP-certified clinical bioanalytical laboratory owned by GSK Germany. The certified clinical bioanalytical laboratory has 80 scientists and analysts. Through a 5-year collaboration agreement, the team of Nexelis will now assist in the development of future vaccine candidates of GSK.
COVID-19 pandemic has further accelerated the growth of the global testing services market during the forecast period. Services companies are investing in bioanalytical platforms to develop new COVID-19 diagnostic testing and develop new drugs to combat the deadly pandemic that is wreaking havoc across the globe.
- ICON plc
- Covance Inc.
- Charles River Laboratories
- inVentiv Health
- Toxikon, Inc.
- Intertek group
- Pace Analytical Services LLC
- SGS SA
Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/bioanalytical-testing-services-market/speak-to-analyst
Polaris Market Research has segmented the bioanalytical testing services market report on the basis of molecule type, workflow, test type, and region
Bioanalytical Testing Services, Molecule Type Outlook (Revenue – USD Million, 2016 – 2028)
- Small Molecule
- Large Molecule
- LC-MS Studies
Bioanalytical Testing Services, Test Type Outlook (Revenue – USD Million, 2016 – 2028)
- Absorption, Distribution, Metabolism, Excretion (ADME)
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
Bioanalytical Testing Services, Workflow Outlook (Revenue – USD Million, 2016 – 2028)
- Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
- Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
- Other Processes
Bioanalytical Testing Services, Regional Outlook (Revenue – USD Million, 2017 – 2028)
- North America (U.S., Canada)
- Europe (France, Germany, Italy, Spain, UK, Netherlands, Austria)
- Asia Pacific (China, India, Japan, South Korea, Malaysia, Indonesia)
- Latin America (Argentina, Brazil, Mexico)
- Middle East & Africa (Israel, Saudi Arabia, South Africa, UAE)
Find more research reports on Healthcare Industry by PMR
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers.
Company Name: Polaris Market Research and Consulting
Contact Person: Mr. Likhil G
Email: Send Email
Address:30 Wall Street 8th Floor
City: New York
State: New York 10005
Country: United States